Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444580) titled 'PrP-targeting siRNA Safety & Mechanism Study' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Broad Institute of MIT and Harvard
Condition:
Prion Disease
Intervention:
Drug: PrP-siRNA
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 30
To know more, visit https://clinicaltrials.gov/study/NCT07444580
Published by HT Digital Content Services with permission from Health Daily Digest....